Karlan BY - Search Results

1

Spatiotemporal architecture of immune cells and cancer-associated fibroblasts in high-grade serous ovarian carcinoma.

Xu AM, Haro M, Walts AE, Hu Y, John J, Karlan BY, Merchant A, Orsulic S. Xu AM, et al. Among authors: karlan by. Sci Adv. 2024 Apr 19;10(16):eadk8805. doi: 10.1126/sciadv.adk8805. Epub 2024 Apr 17. Sci Adv. 2024. PMID: 38630822 Free PMC article.

2

Chemotherapy in epithelial ovarian cancer.

Wang J, Li AJ, Karlan BY. Wang J, et al. Among authors: karlan by. Curr Womens Health Rep. 2002 Feb;2(1):20-6. Curr Womens Health Rep. 2002. PMID: 12112979 Review.

3

Improved survival in women with BRCA-associated ovarian carcinoma.

Cass I, Baldwin RL, Varkey T, Moslehi R, Narod SA, Karlan BY. Cass I, et al. Among authors: karlan by. Cancer. 2003 May 1;97(9):2187-95. doi: 10.1002/cncr.11310. Cancer. 2003. PMID: 12712470 Free article.

4

BRCA-mutation-associated fallopian tube carcinoma: a distinct clinical phenotype?

Cass I, Holschneider C, Datta N, Barbuto D, Walts AE, Karlan BY. Cass I, et al. Among authors: karlan by. Obstet Gynecol. 2005 Dec;106(6):1327-34. doi: 10.1097/01.AOG.0000187892.78392.3f. Obstet Gynecol. 2005. PMID: 16319259

5

Tertiary cytoreductive surgery in recurrent ovarian cancer: selection criteria and survival outcome.

Karam AK, Santillan A, Bristow RE, Giuntoli R 2nd, Gardner GJ, Cass I, Karlan BY, Li AJ. Karam AK, et al. Among authors: karlan by. Gynecol Oncol. 2007 Feb;104(2):377-80. doi: 10.1016/j.ygyno.2006.08.037. Epub 2006 Oct 2. Gynecol Oncol. 2007. PMID: 17014899

6

A role for BRCA1 in uterine leiomyosarcoma.

Xing D, Scangas G, Nitta M, He L, Xu X, Ioffe YJ, Aspuria PJ, Hedvat CY, Anderson ML, Oliva E, Karlan BY, Mohapatra G, Orsulic S. Xing D, et al. Among authors: karlan by. Cancer Res. 2009 Nov 1;69(21):8231-5. doi: 10.1158/0008-5472.CAN-09-2543. Epub 2009 Oct 20. Cancer Res. 2009. PMID: 19843854 Free PMC article.

7

Lynch syndrome among gynecologic oncology patients meeting Bethesda guidelines for screening.

Walsh CS, Blum A, Walts A, Alsabeh R, Tran H, Koeffler HP, Karlan BY. Walsh CS, et al. Among authors: karlan by. Gynecol Oncol. 2010 Mar;116(3):516-21. doi: 10.1016/j.ygyno.2009.11.021. Epub 2010 Jan 19. Gynecol Oncol. 2010. PMID: 20034658 Free PMC article.

8

Does risk-reducing bilateral salpingo-oophorectomy leave behind residual tube?

Cass I, Walts A, Karlan BY. Cass I, et al. Among authors: karlan by. Gynecol Oncol. 2010 Apr;117(1):27-31. doi: 10.1016/j.ygyno.2009.12.023. Epub 2010 Jan 27. Gynecol Oncol. 2010. PMID: 20110118

9

BRCA1-associated epigenetic regulation of p73 mediates an effector pathway for chemosensitivity in ovarian carcinoma.

Ibrahim N, He L, Leong CO, Xing D, Karlan BY, Swisher EM, Rueda BR, Orsulic S, Ellisen LW. Ibrahim N, et al. Among authors: karlan by. Cancer Res. 2010 Sep 15;70(18):7155-65. doi: 10.1158/0008-5472.CAN-10-0668. Epub 2010 Aug 31. Cancer Res. 2010. PMID: 20807817 Free PMC article.

10

Fluvastatin and cisplatin demonstrate synergistic cytotoxicity in epithelial ovarian cancer cells.

Taylor-Harding B, Orsulic S, Karlan BY, Li AJ. Taylor-Harding B, et al. Among authors: karlan by. Gynecol Oncol. 2010 Dec;119(3):549-56. doi: 10.1016/j.ygyno.2010.08.017. Epub 2010 Sep 15. Gynecol Oncol. 2010. PMID: 20837358

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

428 results

Search Page